COMPANY
Judo Bio
With our STRIKE (Selectively Targeting RNA Into KidnEy) platform, we use a proprietary approach that harnesses a natural, endogenous mechanism to target oligonucleotide medicines to the kidney. From company website Source · Oct 12, 2026
Raises and investors new
- InvestorListed in the portfolio of Atlas Venture (captured Oct 12, 2026). portfolio page ↗